163 related articles for article (PubMed ID: 9427711)
1. Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression.
Sun WH; Pabon C; Alsayed Y; Huang PP; Jandeska S; Uddin S; Platanias LC; Rosen ST
Blood; 1998 Jan; 91(2):570-6. PubMed ID: 9427711
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.
Tracey L; Villuendas R; Ortiz P; Dopazo A; Spiteri I; Lombardia L; Rodríguez-Peralto JL; Fernández-Herrera J; Hernández A; Fraga J; Dominguez O; Herrero J; Alonso MA; Dopazo J; Piris MA
Am J Pathol; 2002 Nov; 161(5):1825-37. PubMed ID: 12414529
[TBL] [Abstract][Full Text] [Related]
3. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
4. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.
Wong LH; Krauer KG; Hatzinisiriou I; Estcourt MJ; Hersey P; Tam ND; Edmondson S; Devenish RJ; Ralph SJ
J Biol Chem; 1997 Nov; 272(45):28779-85. PubMed ID: 9353349
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
[TBL] [Abstract][Full Text] [Related]
6. Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression.
Landolfo S; Guarini A; Riera L; Gariglio M; Gribaudo G; Cignetti A; Cordone I; Montefusco E; Mandelli F; Foa R
Hematol J; 2000; 1(1):7-14. PubMed ID: 11920164
[TBL] [Abstract][Full Text] [Related]
7. Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha.
Li X; Leung S; Qureshi S; Darnell JE; Stark GR
J Biol Chem; 1996 Mar; 271(10):5790-4. PubMed ID: 8621447
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
9. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes.
Gimeno R; Lee CK; Schindler C; Levy DE
Mol Cell Biol; 2005 Jul; 25(13):5456-65. PubMed ID: 15964802
[TBL] [Abstract][Full Text] [Related]
10. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid induces signal transducer and activator of transcription (STAT) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons.
Matikainen S; Ronni T; Lehtonen A; Sareneva T; Melén K; Nordling S; Levy DE; Julkunen I
Cell Growth Differ; 1997 Jun; 8(6):687-98. PubMed ID: 9186002
[TBL] [Abstract][Full Text] [Related]
12. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages.
Lehtonen A; Matikainen S; Julkunen I
J Immunol; 1997 Jul; 159(2):794-803. PubMed ID: 9218597
[TBL] [Abstract][Full Text] [Related]
13. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
[TBL] [Abstract][Full Text] [Related]
14. Psoralen with ultraviolet A-induced apoptosis of cutaneous lymphoma cell lines is augmented by type I interferons via the JAK1-STAT1 pathway.
Liszewski W; Naym DG; Biskup E; Gniadecki R
Photodermatol Photoimmunol Photomed; 2017 May; 33(3):164-171. PubMed ID: 28196286
[TBL] [Abstract][Full Text] [Related]
15. Interferon-induced gene expression and signaling in human hepatoma cell lines.
Melén K; Keskinen P; Lehtonen A; Julkunen I
J Hepatol; 2000 Nov; 33(5):764-72. PubMed ID: 11097485
[TBL] [Abstract][Full Text] [Related]
16. Interferon alpha induction of Stat1 and Stat2 and their prognostic significance in carcinoid tumors.
Zhou Y; Wang S; Gobl A; Oberg K
Oncology; 2001; 60(4):330-8. PubMed ID: 11408801
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
[TBL] [Abstract][Full Text] [Related]
19. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3.
Martinez-Moczygemba M; Gutch MJ; French DL; Reich NC
J Biol Chem; 1997 Aug; 272(32):20070-6. PubMed ID: 9242679
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells.
Clifford JL; Yang X; Walch E; Wang M; Lippman SM
Mol Cancer Ther; 2003 May; 2(5):453-9. PubMed ID: 12748307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
